Form 4: Profusa Director O'Rourke Receives Stock Option Awards

Profusa, Inc. Director Peter O'Rourke was granted 274,660 stock options with an exercise price of $0.35, vesting over three years and one year respectively.

Summary

• Peter O'Rourke, a Director of Profusa, Inc. (PFSA), reported the acquisition of stock options.
• An inaugural director award of 221,794 options to purchase common stock was granted, with an exercise price of $0.35 per share.
• These inaugural options vest in three equal annual increments over a period of three years from the closing of the business combination between the Issuer (formerly NorthView Acquisition Corp.) and Profusa, Inc. (the "Closing").
• An annual director award of 52,866 options to purchase common stock was also granted, with an exercise price of $0.35 per share.
• These annual options vest on the first anniversary of the Closing.
• Both sets of options have an expiration date of January 26, 2036.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The granting of stock options to a director is a routine compensation event that aligns interests, which is generally viewed favorably, but it does not reflect operational performance or significant strategic shifts.

Positives

• The granting of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term performance.
• The awards represent standard compensation practice for directors, reflecting ongoing commitment to the company.

Future Outlook

The vesting schedules for the stock options indicate a future alignment of the director's financial interests with the company's long-term performance, with options vesting over one and three-year periods from the business combination's closing date.

Industry Context

The granting of stock options to directors is a common practice across various industries, including biotechnology and medical devices, to attract and retain qualified board members and align their incentives with shareholder value creation.

Comparison to Industry Standards

• Director equity compensation, such as stock options, is a standard component of remuneration packages for board members in publicly traded companies, particularly in growth-oriented sectors like Profusa's.
• The vesting schedules (one and three years) are typical for such awards, designed to encourage long-term commitment and performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The granting of options aligns the director's interests with shareholders, potentially leading to better long-term decision-making aimed at increasing share value.

Next Steps

• The options will vest according to their respective schedules: the inaugural award over three years and the annual award on the first anniversary of the business combination's closing.

Key Dates

Keywords

Profusa, PFSA, stock options, director compensation, insider transaction, Form 4, equity award, beneficial ownership